Market Indices
Sector Heatmap
QURE — uniQure N.V.
NasdaquniQure N.V.
- O
- 22.96
- H
- 23.30
- L
- 22.62
- V
- 1.75M
QURE — Latest News & Headlines
20 StoriesuniQure N.V. (QURE) Stock Price, News, Quote & History - Yahoo! Finance Canada
uniQure N.V. (QURE) Stock Price, News, Quote & History Yahoo! Finance Canada
uniQure stock crashes as Huntington’s gene therapy data weaken - Fierce Biotech
uniQure stock crashes as Huntington’s gene therapy data weaken Fierce Biotech
QURE Stock Just Shot Up 8% - uniQure’s Much-Talked-About Huntington’s Disease Therapy Gets A UK Boost - Stocktwits
QURE Stock Just Shot Up 8% - uniQure’s Much-Talked-About Huntington’s Disease Therapy Gets A UK Boost Stocktwits
QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data - TradingView
QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data TradingView
Why is uniQure stock collapsing today? - Investing.com
Why is uniQure stock collapsing today? Investing.com
QURE Stock Whipsaws As Traders Weigh Cash Pile Against Heavy Losses - StocksToTrade
QURE Stock Whipsaws As Traders Weigh Cash Pile Against Heavy Losses StocksToTrade
Uniqure Plummets 37% On Another Shocking Twist For Its Huntington's Drug - Investor's Business Daily
Uniqure Plummets 37% On Another Shocking Twist For Its Huntington's Drug Investor's Business Daily
Gene Therapy Data Could Be A Big Moment For uniQure Stock (QURE) - Simply Wall Street
Gene Therapy Data Could Be A Big Moment For uniQure Stock (QURE) Simply Wall Street
uniQure Stock Crashed on Its Huntington's Data. Wall Street's Price Target Says the Selloff Went Too Far - 24/7 Wall St.
uniQure Stock Crashed on Its Huntington's Data. Wall Street's Price Target Says the Selloff Went Too Far 24/7 Wall St.
uniQure N.V. (QURE) Discusses Additional Data from Phase I/II AMT-130 Study in Huntington's Disease Highlighting Disease Progression Slowing - Slideshow (NASDAQ:QURE) 2026-09-29 - Seeking Alpha
uniQure N.V. (QURE) Discusses Additional Data from Phase I/II AMT-130 Study in Huntington's Disease Highlighting Disease Progression Slowing - Slideshow (NASDAQ:QURE) 2026-09-29 Seeking Alpha
uniQure: 80% Slowing on Huntington's Score at 3 Years - Stock Titan
uniQure: 80% Slowing on Huntington's Score at 3 Years Stock Titan
Why Is QURE Stock Crashing Today? Huntington’s Disease Data Raises Durability Concerns - Stocktwits
Why Is QURE Stock Crashing Today? Huntington’s Disease Data Raises Durability Concerns Stocktwits
uniQure Stock Plunges On 4-Year Data, But The Approval Path Is Intact (Rating Upgrade) - Seeking Alpha
uniQure Stock Plunges On 4-Year Data, But The Approval Path Is Intact (Rating Upgrade) Seeking Alpha
Why Is uniQure Stock Sinking on Tuesday? - Yahoo Finance
Why Is uniQure Stock Sinking on Tuesday? Yahoo Finance
QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks? - Stocktwits
QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks? Stocktwits
uniQure: Another Selloff On 48-Month Huntington Data; I Am (Marginally) Bullish (QURE) - Seeking Alpha
uniQure: Another Selloff On 48-Month Huntington Data; I Am (Marginally) Bullish (QURE) Seeking Alpha
uniQure plunges 65% as 48-month Huntington’s gene therapy data misses key stat - Yahoo Finance
uniQure plunges 65% as 48-month Huntington’s gene therapy data misses key stat Yahoo Finance
uniQure (QURE) Faces A Fresh AMT 130 Test After Mixed Data, Bargain Or Trap - Yahoo Finance
uniQure (QURE) Faces A Fresh AMT 130 Test After Mixed Data, Bargain Or Trap Yahoo Finance
These stocks that are showing activity before the opening bell on Tuesday. - ChartMill
These stocks that are showing activity before the opening bell on Tuesday. ChartMill
Learn Why The Bull Case For uniQure (QURE) Could Change Following Four Year AMT 130 Data - Simply Wall Street
Learn Why The Bull Case For uniQure (QURE) Could Change Following Four Year AMT 130 Data Simply Wall Street